CDKN2B-AS1 and acute myeloid leukemia: In AML, ANRIL is also essential for maintenance of a leukemic state in the way that it regulates glucose metabolism through targeting ADIPOR1 (adiponectin receptor) and its downstream factors adenosine monophosphate-activated protein kinase (AMPK)/sirtuin 1 (SIRT1) [93].